• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Seeing Is Knowing: Noninvasive Imaging Outperforms Traditional Risk Assessment.

作者信息

Maron David J, Rodriguez Fatima

机构信息

Division of Cardiovascular Medicine and the Stanford Prevention Research Center, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

Division of Cardiovascular Medicine and the Stanford Prevention Research Center, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA; Stanford Center for Digital Health, Stanford University School of Medicine, Stanford, California, USA.

出版信息

J Am Coll Cardiol. 2024 Oct 8;84(15):1404-1406. doi: 10.1016/j.jacc.2024.06.048.

DOI:10.1016/j.jacc.2024.06.048
PMID:39357938
Abstract
摘要

相似文献

1
Seeing Is Knowing: Noninvasive Imaging Outperforms Traditional Risk Assessment.眼见为实：非侵入性成像优于传统风险评估。
J Am Coll Cardiol. 2024 Oct 8;84(15):1404-1406. doi: 10.1016/j.jacc.2024.06.048.
2
Influence of Subclinical Atherosclerosis Burden and Progression on Mortality.亚临床动脉粥样硬化负担和进展对死亡率的影响。
J Am Coll Cardiol. 2024 Oct 8;84(15):1391-1403. doi: 10.1016/j.jacc.2024.06.045.
3
Femoral and Carotid Subclinical Atherosclerosis Association With Risk Factors and Coronary Calcium: The AWHS Study.股动脉和颈动脉亚临床动脉粥样硬化与危险因素及冠状动脉钙的关系：AWHS 研究。
J Am Coll Cardiol. 2016 Mar 22;67(11):1263-74. doi: 10.1016/j.jacc.2015.12.056.
4
Short-Term Progression of Multiterritorial Subclinical Atherosclerosis.多部位亚临床动脉粥样硬化的短期进展。
J Am Coll Cardiol. 2020 Apr 14;75(14):1617-1627. doi: 10.1016/j.jacc.2020.02.026.
5
Women with a low Framingham risk score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis.弗明汉风险评分低且有早发冠心病家族史的女性，亚临床冠状动脉粥样硬化的患病率很高。
Am Heart J. 2005 Dec;150(6):1276-81. doi: 10.1016/j.ahj.2005.02.037.
6
Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we?无症状受试者亚临床动脉粥样硬化筛查：我们能否进行，是否重要，以及我们是否应该进行？
J Am Coll Cardiol. 2010 Jul 6;56(2):98-105. doi: 10.1016/j.jacc.2009.09.081.
7
The Progression and Early detection of Subclinical Atherosclerosis (PESA) study: rationale and design.无症状性动脉粥样硬化（PESA）研究的进展与早期检测：原理与设计。
Am Heart J. 2013 Dec;166(6):990-8. doi: 10.1016/j.ahj.2013.08.024. Epub 2013 Oct 10.
8
Imaging subclinical atherosclerosis: is it ready for prime time? A review.影像学检测亚临床动脉粥样硬化：它已准备好成为主流了吗？一篇综述。
J Cardiovasc Transl Res. 2014 Oct;7(7):623-34. doi: 10.1007/s12265-014-9582-4. Epub 2014 Aug 14.
9
Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19.新冠肺炎患者冠状动脉钙评估的临床和亚临床冠状动脉疾病的影响。
Atherosclerosis. 2021 Jul;328:136-143. doi: 10.1016/j.atherosclerosis.2021.03.041. Epub 2021 Apr 7.
10
Present and future of coronary risk assessment.冠心病风险评估的现状与未来
Eur Heart J Suppl. 2021 Oct 8;23(Suppl E):E123-E127. doi: 10.1093/eurheartj/suab106. eCollection 2021 Oct.

引用本文的文献

1
Cardiovascular Risk Assessment and Lipid-Lowering Therapy Recommendations in Primary Prevention.初级预防中的心血管风险评估及降脂治疗建议
J Clin Med. 2025 Mar 25;14(7):2220. doi: 10.3390/jcm14072220.